12 July 2018

In a large public-private project, supported by 110 million euros by the IMI, a large consortium of researchers will search for biomarkers with which people with autism can be divided into clear subgroups.

Such stratification increases the chance of effective treatments. The Radboud UMC is also involved in the huge project. In 2012 the large European autism research EU-AIMS started. This abbreviation stands for European Autism Interventions - a Multicenter Study for Developing New Medications. The project, which ended at the end of March of this year, has immediately received a successor: AIMS-2. This new project builds on the results that the first program has produced.

Public-private project

The main applicant for AIMS-2 is the British King's College in London, but the researchers at Donders Institute and Radboudumc are also important partners in the project. Professor of psychiatry Jan Buitelaar is co-leader of clinical studies, Professor of Statistical Imaging Neuroscience Christian Beckmann leads the development of new statistical techniques and databases. The public-private project has been awarded by the European IMI, the Innovative Medicines Initiative. With the pharmaceutical companies that participate, the research institutes received a total of 110 million euros to unravel the Autism Spectrum Disorder (AAS) in detail and on that basis develop medication for the various subgroups that fall under ASD.

Related news items

Standing balance capacity is easily overestimated in well-recovered stroke survivors

20 February 2019

In Neurorehabilitation and Neural Repair Jolanda Roelofs and Sander Geurts showed that well-recovered persons in the chronic phase after stroke with clinically no (or only very limited) motor impairment of the affected leg may still show substantial problems with standing balance control.

read more

Imprinted genes during early embryonic development

18 February 2019

René Dirks, with other members from the lab of Hendrik Marks, theme Cancer development and immune defense, show in a paper in Epigenetics & Chromatin that genomic imprinting (genes expressed from the paternal or maternal allele only) is often lost in cultured embryonic stem cells.

read more

The first Radboud Nanomedicine community networking event

14 February 2019

On 7 February 2019 the first Radboud Nanomedicine community networking event took place. The goal of the event was to bring together all those working in the field of nanomedicine at the Radboud University and Radboudumc, irrespective of the theme in which the research is performed.

read more

Research Integrity Round: The ConScience App 15 February 2019

14 February 2019

To introduce the new Netherlands Code of Conduct for Research Integrity we invited ‘Het Acteursgenootschap’ to perform ‘The ConScience App’, a theatre piece designed to move the debate on scientific knowledge. All Radboudumc researchers are invited to attend this event.

read more

Gene involved in colorectal cancer also causes breast cancer

14 February 2019

Judith Grolleman, Nicoline Hoogerbrugge and Richarda de Voer, theme Tumors of the digestive tract, published in Cancer Cell that mutations in the NTHL1 gene, previously associated with colorectal cancer, also cause breast cancer and other types of cancer.

read more

Endometrial natural killer cells remember previous pregnancy

11 February 2019

Dorien Feyaerts, theme Inflammatory diseases, showed that pregnancy induces a memory phenotype on endometrial natural killer cells. However, previous CMV infection is a prerequisite for this memory induction. They published their findings in Cellular and Molecular Immunology.

read more